These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25730287)

  • 1. Successful desensitization of a patient with aplastic anemia to antithymocyte globulin.
    Wolanin SA; Demain JG; Meier EA
    Allergy Rhinol (Providence); 2015 Jan; 6(1):64-7. PubMed ID: 25730287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A successful desensitization protocol for horse-derived antithymocyte globulin in severe aplastic anemia.
    Demir E; Cigerci Günaydın N; Karadaş N; Gülen F; Tanac R; Yılmaz D
    Pediatr Allergy Immunol; 2015 Mar; 26(2):168-72. PubMed ID: 25605658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithymocyte globulin hypersensitivity in bone marrow failure patients.
    Bielory L; Wright R; Nienhuis AW; Young NS; Kaliner MA
    JAMA; 1988 Dec; 260(21):3164-7. PubMed ID: 3263515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case reports of evaluation and desensitization for anti-thymocyte globulin hypersensitivity.
    Millar MM; Grammer LC
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):311-6. PubMed ID: 11061475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and management of hypersensitivity reactions with rabbit anti-thymocyte globulin in pediatric patients.
    Islamoglu C; Arman Bilir O; Ok Bozkaya I; Demirel AC; Toyran M; Ozbek NY; Dibek Misirlioglu E
    Allergy Asthma Proc; 2023 Sep; 44(5):e22-e28. PubMed ID: 37641226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].
    Yu F; Tang SQ; Wang JW
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):479-81. PubMed ID: 17178040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
    Scheinberg P; Townsley D; Dumitriu B; Scheinberg P; Weinstein B; Rios O; Wu CO; Young NS
    Am J Hematol; 2014 May; 89(5):467-9. PubMed ID: 24415649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged renal failure secondary to antithymocyte globulin treatment in severe aplastic anemia.
    Barakat RK; Schmolck JP; Finkel KW; Foringer JR
    Ann Pharmacother; 2007 May; 41(5):895-8. PubMed ID: 17426071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of childhood aplastic anemia with antithymocyte globulin, management of side effects and long-term follow-up].
    Fu XY; Xie XT; Jiang SY; Shi W; Shao YX
    Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):226-30. PubMed ID: 21575376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
    Xie XT; He W; Shi W; Zhou XX; Qiao XH
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Chuncharunee S; Wong R; Rojnuckarin P; Chang CS; Chang KM; Lu MY; Hwang WL; Koh LP; Chen TY; Leung AY; Norasetthada L; Wang SC; Chang MC; Wu KH; Issaragrisil S
    Int J Hematol; 2016 Oct; 104(4):454-61. PubMed ID: 27376944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia.
    Zhang J; Wu Y; Liu J; Han S; Chen L; Wang H; Peng Y
    Ann Palliat Med; 2021 May; 10(5):5549-5560. PubMed ID: 34107711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature.
    Yeung C; Relke N; Good D; Satkunam N; Mates M
    Immunotherapy; 2023 Apr; 15(5):323-333. PubMed ID: 36852421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.